The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models
Year: 2011
Type: article
Source: Oncogene
DOI: 10.1038/onc.2010.625
Authors: E Normant, G Paez, K A West, A R Lim, K L Slocum, C Tunkey, J McDougall, A A Wylie, K Robison, K Caliri, V J Palombella, C C Fritz
Institution: Infinity Pharmaceuticals (United States)
Language: English
Topic: Heat shock proteins research
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2050654618